Nigel R. A. Beeley

1.0k citations

25 papers · 648 indexed · h-index 14

Organic Chemistry top 10%
Molecular Biology
Radiology, Nuclear Medicine and Imaging top 10%
Oncology
Materials Chemistry

Co-authors: Kenneth Millar Andrew T. Millican Byron A. Boyce David Parker Karl J. Jankowski Michael A. W. Eaton Carleton R. Sage J. P. Cox
Topics: Monoclonal and Polyclonal Antibodies Research (6 papers)Chemical Synthesis and Analysis (5 papers)Click Chemistry and Applications (4 papers)
Cited by: Radiology, Nuclear Medicine and Imaging Organic Chemistry Oncology
Journals: Diabetes Biochemical Journal Tetrahedron
Partner nations: United Kingdom United States Japan

In The Last Decade

Nigel R. A. Beeley

24 papers receiving 600 citations

Peers

Countries citing papers authored by Nigel R. A. Beeley

Since Specialization

Citations

This map shows the geographic impact of Nigel R. A. Beeley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nigel R. A. Beeley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nigel R. A. Beeley more than expected).

Fields of papers citing papers by Nigel R. A. Beeley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nigel R. A. Beeley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nigel R. A. Beeley. The network helps show where Nigel R. A. Beeley may publish in the future.

Co-authorship network of co-authors of Nigel R. A. Beeley

This figure shows the co-authorship network connecting the top 25 collaborators of Nigel R. A. Beeley. A scholar is included among the top collaborators of Nigel R. A. Beeley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nigel R. A. Beeley. Nigel R. A. Beeley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	6-LB: GPR119 Agonist PRM A Increases Glucagon Response to Hypoglycemia in Rats 2023 ·Diabetes ·(unknown),(unknown),Nigel R. A. Beeley,David Kelley	0
2	Discovery of 4-(dimethylamino)quinazolines as potent and selective antagonists for the melanin-concentrating hormone receptor 1 2005 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),(unknown),Takeo Funakoshi,Shigeyuki Chaki,Graeme Semple,Thuy-Anh Tran,(unknown),(unknown),Martin D. Casper,(unknown),Nigel R. A. Beeley,Yoshinori Sekiguchi	23
3	Discovery and SAR of new benzazepines as potent and selective 5-HT2C receptor agonists for the treatment of obesity 2005 ·Bioorganic & Medicinal Chemistry Letters ·Brian M. Smith,Jeffrey M. Smith,James H. Tsai,Jeffrey A. Schultz,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Dipanjan Sengupta,William Thomsen,(unknown),Kevin Whelan,(unknown),Robert R. Webb,Nigel R. A. Beeley	70
4	GPCRs: an update on structural approaches to drug discovery 2003 ·Nigel R. A. Beeley,Carleton R. Sage	31
5	Medicinal Chemistry – An Introduction 2001 ·Drug Discovery Today ·Nigel R. A. Beeley	38
6	Can peptides be mimicked? 2000 ·Drug Discovery Today ·Nigel R. A. Beeley	24
7	Section Review Oncologic, Endocrine & Metabolic: The amylin, CGRP and calcitonin family of peptides 1996 ·Expert Opinion on Therapeutic Patents ·Nigel R. A. Beeley,K S Prickett	7
8	An in Vivo Model for Screening Peptidomimetic Inhibitors of Gelatinase A 1995 ·Journal of Pharmaceutical Sciences ·Surinder K. Chander,Pari Antoniw,Nigel R. A. Beeley,Byron A. Boyce,Thomas Crabbe,Andrew Docherty,J. C. Leonard,Barbara Mason,Kenneth Millar,Andrew T. Millican,Richard Morphy,Andrew Mountain,James P. O’Connell,John Porter,N. Willmott	10
9	Peptidomimetics and small-molecule drug design: Towards improved bioavailability and in vivo stability 1994 ·Trends in biotechnology ·Nigel R. A. Beeley	12
10	Potent and selective inhibitors of gelatinase-a 1. hydroxamic acid derivatives 1994 ·Bioorganic & Medicinal Chemistry Letters ·John Porter,Nigel R. A. Beeley,Byron A. Boyce,Barbara Mason,Andrew T. Millican,Kenneth Millar,J. C. Leonard,J. Richard Morphy,James P. O’Connell	33
11	Conformational differences in two mutant hinge IgG4 antibodies observed by scanning tunneling microscopy 1994 ·Journal of Vacuum Science & Technology B Microelectronics and Nanometer Structures Processing Measurement and Phenomena ·(unknown),John R. Adair,Nigel R. A. Beeley,Martyn C. Davies,David E. Jackson,Clive J. Roberts,(unknown),Philip M. Williams	6
12	A general synthesis of N-substituted isothiazol-3(2H)-ones 1994 ·Journal of the Chemical Society Perkin Transactions 1 ·Nigel R. A. Beeley,Laurence M. Harwood,(unknown)	12
13	ChemInform Abstract: Synthesis of New Macrocyclic Amino‐Phosphinic Acid Complexing Agents and Their C‐ and P‐Functionalized Derivatives for Protein Linkage. 1992 ·ChemInform ·(unknown),(unknown),Karl J. Jankowski,David Parker,(unknown),Byron A. Boyce,Nigel R. A. Beeley,(unknown),Andrew T. Millican	2
14	Overview: Macrocyclic Chelators as Anticancer Agents in Radioimmunotherapy 1992 ·Nigel R. A. Beeley,(unknown)	1
15	The in vivo release of 90Y from cyclic and acyclic ligand-antibody conjugates 1991 ·International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology ·A. Harrison,(unknown),David Parker,Karl J. Jankowski,J. P. Cox,Andrew S. Craig,J. M. Sansom,Nigel R. A. Beeley,Rich Boyce,L Chaplin,Michael A. W. Eaton,(unknown),Kenneth Millar,Andrew T. Millican,(unknown),(unknown),(unknown),Alison Turner	62
16	Cephalosporin Nitrogen Mustard Carbamate prodrugs for “ADEPT”. 1991 ·Tetrahedron Letters ·Rikki Alexander,Nigel R. A. Beeley,(unknown),(unknown),T.A. Millican,Andrew J. Pratt,Frances Willenbrock	53
17	Structural studies on the [But-Cys18](19-37)-fragment of human β-calcitonin-gene-related peptide 1991 ·Biochemical Journal ·(unknown),(unknown),Nigel R. A. Beeley,Saul J. B. Tendler	9
18	Synthesis of C- and N-functionalised derivatives of 1,4,7-triazacyclononane-1,4,7-triyltriacetic acid (NOTA), 1,4,7,10-tetra-azacyclododecane-1,4,7,10-tetrayltetra-acetic acid (DOTA), and diethylenenetriaminepenta-acetic acid (DTPA): bifunctional complexing agents for the derivatisation of antibodies 1990 ·Journal of the Chemical Society Perkin Transactions 1 ·J. P. Cox,Andrew S. Craig,I. M. HELPS,Karl J. Jankowski,David Parker,Michael A. W. Eaton,Andrew T. Millican,Kenneth Millar,Nigel R. A. Beeley,Byron A. Boyce	66
19	Synthesis of a kinetically stable yttrium-90 labelled macrocycle–antibody conjugate 1989 ·Journal of the Chemical Society Chemical Communications ·J. P. Cox,Karl J. Jankowski,Ritu Kataky,David Parker,Nigel R. A. Beeley,Byron A. Boyce,Michael A. W. Eaton,Kenneth Millar,Andrew T. Millican,Alice Harrison,(unknown)	65
20	Syntheses of PGF2α, and cloprostenol 1981 ·Tetrahedron ·Nigel R. A. Beeley,(unknown),J. K. SUTHERLAND,(unknown),(unknown),(unknown)	18

About Nigel R. A. Beeley

Nigel R. A. Beeley is a scholar working on Organic Chemistry, Radiology, Nuclear Medicine and Imaging and Biotechnology, having authored 25 papers that have together received 648 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (6 papers), Chemical Synthesis and Analysis (5 papers) and Click Chemistry and Applications (4 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (223 citations), Organic Chemistry (238 citations) and Oncology (144 citations). Nigel R. A. Beeley has collaborated with scholars based in United Kingdom, United States and Japan. Frequent co-authors include Kenneth Millar, Andrew T. Millican, Byron A. Boyce, David Parker, Karl J. Jankowski, Michael A. W. Eaton, Carleton R. Sage, J. P. Cox, Andrew S. Craig and I. M. HELPS. Their work appears in journals such as Diabetes, Biochemical Journal and Tetrahedron.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact